Evotec - Research never stops
  • Loading...

Our Partners

Boehringer Ingelheim

Evotec and Boehringer Ingelheim enter into multi-year, multi target collaboration

- read more

CHDI

CHDI selects Evotec as strategic drug discovery partner in the search for Huntington's disease treatments

- read more

Pfizer

VR1 antagonist program

- read more

Roche

Global alliance to jointly discover novel drugs

- read more

Novartis

Three year drug discovery collaboration to identify and develop novel small molecule therapeutics

- read more

Ono

Extension of research collaboration with Ono to include an ion channel target

- read more

InterMune

Fragment-based drug discovery program yields results and leads to expansion of collaboration with InterMune

- read more

Spermatech

Spermatech selects Evotec as partner for high-throughput screening and lead discovery to identify small molecule therapeutics for their pharmaceutical discovery project

- read more

Cubist

Research agreement on fragment-based drug discovery

- read more

Biogen Idec

Evotec announces Research Agreement with Biogen Idec focusing on hit identification

- read more